Correlation Between Advanced Proteome and Protokinetix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Advanced Proteome and Protokinetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Advanced Proteome and Protokinetix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Advanced Proteome Therapeutics and Protokinetix, you can compare the effects of market volatilities on Advanced Proteome and Protokinetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Advanced Proteome with a short position of Protokinetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Advanced Proteome and Protokinetix.

Diversification Opportunities for Advanced Proteome and Protokinetix

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Advanced and Protokinetix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Advanced Proteome Therapeutics and Protokinetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protokinetix and Advanced Proteome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Advanced Proteome Therapeutics are associated (or correlated) with Protokinetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protokinetix has no effect on the direction of Advanced Proteome i.e., Advanced Proteome and Protokinetix go up and down completely randomly.

Pair Corralation between Advanced Proteome and Protokinetix

Assuming the 90 days horizon Advanced Proteome Therapeutics is expected to under-perform the Protokinetix. But the pink sheet apears to be less risky and, when comparing its historical volatility, Advanced Proteome Therapeutics is 1.97 times less risky than Protokinetix. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Protokinetix is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2.35  in Protokinetix on August 28, 2024 and sell it today you would lose (1.41) from holding Protokinetix or give up 60.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Advanced Proteome Therapeutics  vs.  Protokinetix

 Performance 
       Timeline  
Advanced Proteome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Protokinetix 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.

Advanced Proteome and Protokinetix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Advanced Proteome and Protokinetix

The main advantage of trading using opposite Advanced Proteome and Protokinetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Advanced Proteome position performs unexpectedly, Protokinetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protokinetix will offset losses from the drop in Protokinetix's long position.
The idea behind Advanced Proteome Therapeutics and Protokinetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments